Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Higher levels of small, dense LDL cholesterol are linked to a greater risk of heart attack in young adults.

Male relatives of women with PCOS show similar health issues, suggesting a male version of the condition.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Osteoporotic postmenopausal Sudanese women have a high risk of cardiovascular disease.

Bergamot may improve heart health, skin conditions, and mood, but more research is needed to confirm these benefits.

Patients with mycosis fungoides have a higher risk of heart disease.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Women with PCOS have higher irisin levels, which may affect their metabolism and hormones.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Higher LDL cholesterol may increase the risk of hair loss, while HDL cholesterol does not.

Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Premature hair greying may indicate a higher risk of metabolic problems.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

The treatments for fungal nail infection, hair loss in men, benign nail tumor, and chemotherapy-associated nail bed inflammation are effective and safe.